Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Brand Concepts Limited specializes in the design and distribution of apparel and footwear, primarily targeting the Indian market. The company operates a portfolio of brands, including both proprietary and licensed products, leveraging its extensive retail network to drive sales across various consumer segments.
Brand Concepts generates revenue through direct sales of its apparel and footwear products, both online and through physical retail channels. The company benefits from strong brand recognition and a diverse product portfolio, allowing it to maintain pricing power despite competitive pressures.
Consumer spending trends in India, particularly in the apparel sector
Changes in raw material costs affecting margins
Brand expansion initiatives, including new product launches
Retail foot traffic and e-commerce growth rates
Shifts in consumer preferences towards sustainable and ethical fashion
Regulatory changes affecting import tariffs on materials
Intensifying competition from both domestic and international apparel brands
E-commerce giants expanding their private label offerings
High debt-to-equity ratio (2.20) raises concerns about financial stability
Negative free cash flow indicates potential liquidity issues
high - The company is closely tied to consumer discretionary spending, which tends to fluctuate with economic cycles and GDP growth.
Higher interest rates can increase financing costs for inventory and expansion, potentially squeezing margins and reducing consumer spending on non-essential goods.
minimal - The company does not heavily rely on credit for operations, but high debt levels could impact financial flexibility.
growth - Investors looking for turnaround potential and revenue growth in a recovering consumer market.
high - The stock has shown significant price fluctuations, evidenced by a 43.9% decline over the past year.
